植物雷公藤主要抗癌抗炎活性成分研究进展

摘要/Abstract

摘要：

我国传统医学成功应用雷公藤治疗免疫系统疾病及炎性疾病已有数百年历史。目前为止，超过46种二萜类化合物，20种新型三萜类化合物，21种生物碱类化合物及其他小分子化合物已从雷公藤植物中分离鉴定出来。其中环氧化二萜类化合物雷公藤甲素、三萜烯类化合物雷公藤红素及雷公藤甲素衍生物-雷公藤氯内酯醇具有强大的抗炎抗癌活性。现针对上述三种成分的抗炎、抗癌作用及机制，以及其在癌症及炎性疾病治疗方面潜在的临床应用价值作一综述。

关键词: 雷公藤, 雷公藤甲素, 雷公藤红素, 雷公藤氯内酯醇, 抗癌, 抗炎

Abstract:

Tripterygium wilfordii (TW) is a Chinese medicine herb which has been used widely and successfully for centuries in treating immunological disorders and inflammatory diseases. Up to now more than 46 diterpenoids, 20 new triterpenoids, 26 alkaloids and other small molecules have been isolated and identified from this plant. The diterpenoid epoxide triptolide, the quinone triterpene celastrol and the triptolide derivative tripchlorolide are amomg the bioactive compounds of TW with potent anti-inflammatory and anticancer effects.This review discusses mechanistic studies into these three bioactive compounds and illustrates their potential clinical use in the treatment of cancer and inflammatory diseases.

Key words: Tripterygium wilfordii, triptolide, celastrol, tripchlorolide, anticancer, anti-inflammation

中图分类号:

R285

刘文成，谭布珍，方玉婷，占欣璐，王玉. 植物雷公藤主要抗癌抗炎活性成分研究进展[J]. 中国临床药理学与治疗学, 2017, 22(3): 355-360.

LIU Wencheng, TAN Buzhen，FANG Yuting, ZHAN Xinlu, WANG Yu. Progress of the study of anticancer and anti-inflammatory bioactive compounds of Tripterygium wilfordii[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 355-360.

参考文献

［1］Wang HL, Jiang Q, Feng XH, et al. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis［J］. BMC Complement Alternat Med, 2016, 16: 215.
［2］Yin SY,Wei WC,Jian FY,et al.Therapeutic applications of herbal medicines for cancer patients［J］.Evid Based Complement Alternat Med,2013,302:426.
［3］Wong KF, Yuan Y, Luk JM. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents［J］. Clin Exp Pharmacol Physiol, 2012, 39(3): 311-320.
［4］Wang X, Zhang L, Duan W, et al. Anti-inflammatory effects of triptolide by inhibiting the NF-κB singnaling pathway in LPS-induced acute lung injury in a murine model［J］. Mol Med Rep, 2014, 10(1): 447-452.
［5］Shen YF,Zhang X,Wang Y,et al. Celastrol targets IRKs to block Toll-like 4-mediated nuclear factor-κB activation［J］.J Integr Med,2016,14(3):203-208.
［6］Ziaei S, Haiaby R. Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review ［J］. Avicenna J Phytomed, 2016, 6(2): 149-164.
［7］Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers ［J］. Cancer Immunol Res, 2014, 2(9): 823-830.
［8］Chen XW, Peng SN, Zeng HH, et al. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy［J］. Indian Pharmacol, 2015,47(1): 27-33.
［9］He L, Peng X, Liu G, et al. Anti-inflammatory effects of triptolide on IgA nephropathy in rats［J］. Immunopharmacol Immunotoxicol, 2015, 37(5): 421-427.
［10］Peng AP, Wang XY, Zhuang JH. Triptolide inhibits Th17 cell differentiation via regulating cyclooxygenase-2/prostaglandin E2 axis in synovial fibroblasts from rheumatoid arthritis［J］. Zhongguo Zhong Yao Za Zhi, 2014, 39(3): 536-539.
［11］Liu LX, Lee NP, Chan VW, et al. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma［J］. Hepatology, 2009, 50(5): 145-163.
［12］Sun B, Hu S, Li Y, et al. Triptolide contributes to decrease in TLR4 expression by upregulating miR-224-3p to inhibit the inflammatory reaction in diabetic nephropathy［J］. Oncatarget, 2016, 7(51): 856-875.
［13］Peng A,Huang X,Liu R,et al.Triptolide inhibits the inflammatory response of monocytes from rheumatoid arthritis patients by regulating miR-155［J］.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2014,30(6):635-638.
［14］Sun YY, Xiao L, Wang D, et al. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53［J］. Int J Oncol, 2017, 10, 3892.
［15］Pei LJ, Li JD, Zhao ZH, et al. Effect of triptolide on human oral cancer cell proliferation and PTEN gene mRNA expression in oral cancer［J］. Zhonghua Kou Qiang Yi Xue Za Zhi, 2017, 52(1): 44-47.
［16］Ding X, Zhou X, Jiang B, et al. Triptolide suppresses proliferation ,hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells［J］. Mol Med Rep, 2015, 12(3): 4508-4513.
［17］Meng C, Zhu H, Song H, et al. Targets and molecular mechanisms of triptolide in cancer therapy［J］. Chin J Cancer Res, 2014, 25(5): 622-626.
［18］Jonson SM, Wang X, Evers BM. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors［J］. J Surg Res, 2011, 168(2): 197-205.
［19］Reno TA, Kim JY, Raz DJ. Triptolide inhibits lung cancer cell migration,invasion,and metastasis［J］. Ann Thorao Surg, 2015, 100(5): 1817-1824.
［20］Zhang W, Kang M, Zhang T, et al. Triptolide combined with radiotherapy for the treatment of nasopharyngeal carcinoma via NF-κB-related mechanism［J］. Int J Mol Sci, 2016, 17(12): 2139.
［21］Xie CQ, Zhou P, Zuo J, et al. Triptolide exerts pro-apoptotic and cell cycle arrest on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways［J］. Oncoll Lett, 2016, 12(5): 3586-3590.
［22］Hu H, Luo L, Liu F, et al. Anti-cancer and sensibilisation effect of triptolide on human epithelial ovarian cancer［J］. J Cancer, 2016, 7(14): 2093-2099.
［23］Gan K, Xu L, Feng X, et al. Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7［J］. Int Immunophamacol, 2015, 24(2): 239-246.
［24］Peng X,Wang J,Li X,et al.Targeting mast cells and basophils with anti-FcεRIα Fab-conjugated celastrol-Loaded micelles suppresses allergic inflammation［J］.J Biomed Nanotechnol,2015,11(12):2286-2299.
［25］Yu X,Tao W,Jiang F,et al.Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1［J］.Am J Hypertens,2010,23(8):895-903.
［26］Yu Y, Koehn CD, Yue Y, et al. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation［J］. Curr Mol Med, 2015, 15(4): 401-410.
［27］Zhao Y, Zhao H, Lobo N, et al. Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro［J］. J Aizheimers Dis, 2014, 41(3): 835-844.
［28］Li G, Liu D, Zhang Y, et al. Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression［J］. PLos One, 2013, 8(7): e68905.
［29］Kannaiyan R, Shanmugam MK, Sethi G. Molecular targets of celastrol derived from thunder of god vine:potential role in the treatment of inflammatory disorders and cancer［J］. Cancer Lett, 2011, 303(1): 9-20.
［30］Zhao J, Sun Y, Shi P, et al. Celastrol ameliorates experimental colitis in IL-10 deficient mice via up-regulation of autophagy［J］. Int Immunopharmacol, 2015, 26(1): 22-28.
［31］Chen G, Zhang X, Zhao M, et al. Celastrol targets mitochondrial respiatory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells［J］. BMC Cancer, 2011, 11: 170.
［32］Yu X, Zhou X, Fu C, et al. Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway［J］. Oncol Rep, 2015, 34(3): 1129-1136.
［33］Li PP, He W, Yuan PF, et al. Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells［J］. Am J Chin Med, 2015, 43(1): 137-148.
［34］Sha M, Ye J, Zhang LX, et al. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/AKT-NF-κB signaling pathway［J］. Pharmacology, 2014, 93(1/2): 39-46.
［35］Guo J, Huang X, Wang H, et al. Celastrol induces autophagy by targeting AR/miR-101 in prostate cancer cells［J］. PLos One, 2015, 10(10): e0140745.
［36］Huang L, Zhang Z, Zhang S, et al. Inhibitory action of celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1 alpha pathway［J］. Int J Mol Med, 2011, 27(3): 441-446.
［37］Lee JH, Choi KJ, Seo WD, et al. Ehancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90［J］. Int J Mol Med, 2011, 27(1): 231-236.
［38］Zeng Y, Zhang J, Zhu Y, et al. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease［J］. J Neurochem, 2015, 133(1): 38-52.
［39］Zhang J, Zeng YQ, Zhang J, et al. Tripchlorolide ameliorates experimental autoimmune encephalomyelitis by down-regulating ERK1/2-NF-κB and JAK/STAT signaling pathways［J］. J Neurochem, 2015, 133(1): 104-112.
［40］Chen L, Liu Q, Huang Z, et al. Tripchlorolide induces cell death in lung cancer cells by autophagy［J］. Int J Oncol, 2012, 40(4): 1066-1070.
［41］Kim HJ, Ravichandran K, Ozkok A, et al. The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury［J］. J Phamacol Exo Ther, 2014, 349(3): 518-525.
［42］Wang L,Xu Y,Fu L,et al.(5R)-5-hydroxytriptolide (LLDT-8),a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition［J］.Cancer Lett,2012,324(1):75-82.
［43］Kitzen JJ, de Jonge MJ, Lamers CH, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours［J］. Eur J Cancer, 2009, 45(10): 1764-1772.
［44］Wang PY, Zeng WJ, Liu J, et al. TRC4,an improved triptolide derivative,specifically targets to truncated form of retinoid X receptor-alpha in cancer cells［J］. Biochem Pharmacol, 2017, 124: 19-28.
［45］Tang WJ, Wang J, Tong X, et al. Design and synthesis of celastrol derivatives as anticancer agents［J］. Euro J Med Chem, 2015, 95: 166-173.

[1]	许宜琪, 吴茜, 刘书, 刘帆, 邢春燕, 李勤, 何俊俊, 何春玲, 赵咏莉, 高家林. 雷公藤多苷治疗糖尿病肾脏病的临床疗效及抗炎抗纤维化分析[J]. 中国临床药理学与治疗学, 2023, 28(9): 1034-1042.
[2]	梁宏宇, 张海林, 尹欢心, 陈凡, 陆俊霖, 朱才红, 胡伟, 周仁鹏. 2-APB通过下调TRPM7在小鼠皮肤创伤愈合中的作用[J]. 中国临床药理学与治疗学, 2022, 27(7): 747-753.
[3]	陈宇罡, 屠艳琼, 王聪庆, 陈娟, 张博宏. 应用网络药理学和分子对接技术探讨金虎通胆汤治疗胆石症的作用机制及实验验证[J]. 中国临床药理学与治疗学, 2022, 27(10): 1090-1098.
[4]	邓颖, 白殊同. 金圣草黄素相关药理作用机制的研究进展 [J]. 中国临床药理学与治疗学, 2022, 27(10): 1155-1162.
[5]	彭静, 宋静, 栾家杰. 新型冠状病毒肺炎治疗新策略：间充质干细胞疗法[J]. 中国临床药理学与治疗学, 2021, 26(9): 1073-1079.
[6]	王睿, 潘进进, 李华, 袁予辉. 褪黑素调节肺动脉高压的作用与机制研究进展[J]. 中国临床药理学与治疗学, 2021, 26(4): 444-448.
[7]	祁芹，何祥，王刚，那莎，吕磊，陈光亮. 萆薢总皂苷抗炎镇痛作用的实验研究[J]. 中国临床药理学与治疗学, 2020, 25(3): 257-264.
[8]	王艳红, 蒲君峰, 李红玲, 冯铁新. 锰超氧化物歧化酶模拟物对三硝基苯磺酸诱导溃疡性结肠炎大鼠的保护作用及机制研究[J]. 中国临床药理学与治疗学, 2020, 25(10): 1081-1087.
[9]	胡培培，黄芳. 云南白药通过抗炎作用缓解碘乙酸钠诱导的大鼠膝骨关节炎疼痛[J]. 中国临床药理学与治疗学, 2019, 24(3): 254-259.
[10]	俞玲，张根葆，孙淑萍. 皖南地区眼镜蛇毒活性组分外用镇痛的效应及机制研究[J]. 中国临床药理学与治疗学, 2018, 23(11): 1235-1239.
[11]	王棣，张欢欢，方杰，钟宇森，余陈欢. 柠檬苦素对脂多糖致小鼠急性肺损伤的作用[J]. 中国临床药理学与治疗学, 2018, 23(1): 8-12.
[12]	黄海，刘长江，金小越. 阿那其根醇提取物对两种炎症模型作用机制研究[J]. 中国临床药理学与治疗学, 2018, 23(1): 47-50.
[13]	顾惠琴，赵昂，周艳芬，李静，范丽，王聪，郭素菡，王宇，张琪,马博. 基于代谢组学技术对雷公藤多苷和奥硝唑诱导大鼠弱精子症的病理机制研究[J]. 中国临床药理学与治疗学, 2017, 22(7): 721-730.
[14]	刘文成，谭布珍，占欣璐，胡辉，黄根华，曹青. 雷公藤多苷增强耐顺铂人上皮性卵巢癌SKOV3/DDP细胞株顺铂敏感性的体外研究[J]. 中国临床药理学与治疗学, 2017, 22(12): 1364-1370.
[15]	陈美灵，周珮珮，许淑红，崔亚娇，吴玉林. 地氯雷他定的抗炎机制研究进展[J]. 中国临床药理学与治疗学, 2016, 21(3): 335-340.